RISHP LUNCH & LEARN 14: Toxicological Management of Novel Anticancer Treatments: Adoptive Cell Therapy

  • Wednesday, April 28, 2021
  • 12:00 PM - 1:00 PM
  • Online
  • 56

Registration


Registration is closed

Rhode Island Society of Health System Pharmacists 

RISHP LUNCH & LEARN 14: Toxicological Management of Novel Anticancer Treatments: Adoptive Cell Therapy

Pharmacists

Wednesday April 28, 2021

12:00pm to 1:00pm

Online Webinar Registration Details in Confirmation Email

Topics:

Lunch & Learn 14: Toxicological Management of Novel Anticancer Treatments: Adoptive Cell TherapyVerona Abdelmeseh, PharmD, PGY2 Oncology Pharmacy Resident, Rhode Island Hospital
Preceptor: Andrea Monckeberg, MS, RPh, BCOP, Clinical Pharmacy Specialist – Investigational Drug Services

Members:  FREE

Non-Members:  $10

Please register on-line only. Please do not mail in registrations. Fees are payable at sign-in or online via Paypal Online:http://www.rishp.org. Refund requests must be made by written request and are at the discretion of the RISHP Board of Directors.

Learning Objectives

At the completion of this activity, pharmacists will be able to:

1. Describe mechanisms of adoptive cell therapy and bi-specific antibodies.

2. Explain the common toxicities associated with different agents.

3. Summarize commonly accepted grading scales and trouble with standardization.

4. Discuss management strategies of cytokine release syndrome (CRS) and immune effector cell associated neurotoxicity syndrome (ICANS).

5. Identify future therapies that are currently under investigation.


T
he University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge-based educational activity. Pharmacists will receive 1.0 live contact hour (0.1 ceus) for the educational activity. No partial credit is available.
UNIVERSAL ACTIVITY NUMBER (UAN) 0060-9999-21-018-L01-P
PROGRAM EVALUTION
All participants will have the opportunity to evaluate the educational session and speaker and to identify future educational needs.
REQUIREMENTS FOR CE CREDIT
A program evaluation must be completed at www.uripharmacycpd.org within 60 days of the live program date (4/28/2021) in order to receive CE credit. CE credit will be transferred to the CPE Monitor upon successful completion of the program evaluation. Transfer of CE credit should be verified at mycpemonitor.net where CE statements are available to print. Please refer to the evaluation instructions that follow for completing program evaluations and reporting CE credit.
FACULTY DISCLOSURE
Dr. Abdelmeseh has no relevant financial relationships to disclose.



    For website issues issues, please click here

    Powered by Wild Apricot Membership Software